TiUnite Proven Successful Once AgainFeatured Products Promotional Features
Posted by: The Probe 29th December 2017
Over the past 17 years, Nobel Biocare’s TiUnite implant surface has proven highly successful.
Setting the scientific standard for supporting evidence, TiUnite has been evaluated in more than 465 publications, featuring over 89,500 implants in more than 22,600 patients, with the longest mean follow up of 11.2 years.
It has also been the subject of the largest ever meta-analysis of a single implant brand, which confirmed that implants with a TiUnite surface:
• Show remarkably low early failure rates and support long-term clinical survival
• Deliver early implant- and patient-level survival rates that exceed 99% at one year, and late implant-level survival rate at an estimated 95.1% after 10 years
The TiUnite implant surface has also been associated with a low prevalence of peri-implantitis,ii, excellent bone maintenance over 8.5 years for implants in direct contact with soft tissue, and stable bone levels over 10 years.
To find out more about the benefits of TiUnite and the extensive clinical research supporting the implant surface, contact Nobel Biocare today.
For more information about Nobel Biocare, please call 0208 756 3300,
or visit www.nobelbiocare.com
No comments yet.
Sorry, the comment form is closed at this time.